Interplay between bone marrow adiposity and bone resorption in RANKL-mediated modelled osteoporosis

Area of Science:

• Endocrinology
• Bone Biology
• Metabolic Research

Background:

• Bone marrow adipose tissue (BMAT) increases in osteoporosis, but its role in bone resorption is unclear.
• Osteoporosis involves increased bone resorption and changes in bone marrow microenvironment.

Purpose of the Study:

• To investigate mechanisms promoting BMAT expansion in osteoporosis.
• To analyze the spatiotemporal relationship between BMAT and bone resorption in a genetic osteoporosis model.

Main Methods:

• Utilized TgRANKL transgenic mice and wild-type (WT) littermates.
• Analyzed BMAT expansion, bone resorption, and RANKL expression.
• Performed ex vivo adipogenesis assays and tested therapeutic interventions (alendronate, PPARγ antagonists).

Main Results:

• TgRANKL mice showed increased BMAT expansion correlated with bone loss and RANKL levels.
• Bone resorption preceded BMAT development; BMAT produced RANKL.
• Osteoclast supernatants enhanced adipogenesis; alendronate reduced BMAT and improved bone mass.
• PPARγ antagonists reduced BMAT but did not reverse osteoporosis.

Conclusions:

• Bone resorption and osteoclast activity are critical drivers of BMAT expansion in osteoporosis.
• BMAT expansion is a consequence, not a primary cause, of osteolytic bone disease.
• TgRANKL mice are valuable models for studying BMAT in osteolytic diseases.